Nasopharyngeal angiofibroma is a histologically benign but locally aggressive vascular tumor that grows in the back of the nasal cavity. It most commonly affects adolescent males and may grow into fissures of the. Nasoangiofibroma youth is a highly vascularized tumor almost exclusively male adolescents presentation. % represents % of head and. Angiofibroma nasofaring juvenile – Free download as PDF File .pdf), Text File . txt) or read online for free.
|Published (Last):||16 June 2011|
|PDF File Size:||2.34 Mb|
|ePub File Size:||2.29 Mb|
|Price:||Free* [*Free Regsitration Required]|
Numerical sex chromosome aberrations in juvenile angiofibromas: The infratemporal fossa approach for nasopharyngeal tumors. Provisional diagnosis of nasopharyngeal angiofibroma, soft tissue nasovaring, nasopharyngeal polyp or vascular tumor was made.
Juvenile nasopharyngeal angiofibroma | Radiology Reference Article |
The color depends on the vascular component and may vary from pale white in less vascular lesions to a pink and wine colored mass in highly vascularized ones. Prognosis for nasopharyngeal angiofibroma is favorable. A higher density toward the periphery is noted, which was seen in the present case too.
Olfactory neuroblastoma Olfactory nasfoaring. Eventually, the tumor may invade the infratemporal fossa and the middle cranial fossa. It is angiofibrona aggressive neoplasm and shows a propensity for destructive local spread often extending to the base of the skull and into the cranium.
Juvenile nasopharyngeal angiofibroma
Ear Nose Throat J. Received Jul 15; Accepted Jun 1. The origin and development of JNA is not fully understood. Endoscopic approach is an excellent tool in primary and recurrent JNA, it allows visualisation and precise removal of the lesion.
Histopathology reveals a fibrocellular stroma with spindle cells and haphazard arrangement of collagen interspersed with an irregular vascular pattern. Numerous mast cells were noted with a minimal inflammatory cell infiltrate.
Two types of lateral extension in juvenile nasopharyngeal angiofibroma: The blood vessels are slit-like or dilated, organized in clusters and are of different calibers. Fisch classification, however, is currently accepted. Author information Article notes Copyright and License information Disclaimer.
JNA is an uncommon benign tumor predominantly affecting adolescent males. Findings are similar angiofibroja those described above. JNA is benign but locally destructive. Typically a lobulated non-encapsulated soft tissue mass is demonstrated centred on the sphenopalatine foramen which is often widened and usually bowing the posterior wall of the maxillary antrum anteriorly. Case 5 Case 5.
Nasopharyngeal angiofibroma – Wikipedia
The prevalence nasovaring males may be explained by high androgen receptor AR expression suggesting that JNA is androgen dependent. Consistent expression of estrogen receptor beta.
About Blog Go ad-free. Avid enhancement is noted on contrast-enhanced CT.
Juvenile nasopharyngeal angiofibromas are benign but highly vascular tumours. Imaging in the diagnosis of juvenile nasopharyngeal angiofibroma.
Case 7 Case 7. A wait and watch policy with periodic imaging may thus postpone or eliminate the need for surgery and reduce morbidity.
The presence of prominent flow voids lead to a anfiofibroma and pepper appearance on most sequences and are characteristic 5,6.
Mast cells and T-lymphocytes in juvenile angiofibromas. CT images show a heterodense mass that is centered in the sphenopalatine foramen. These discrepancies nasifaring be due to the monoclonal antibodies which detect only alpha-ER and not the beta ER protein. Loss of expression of GSTM 1 null genotype is seen in this tumor.
However, these tumors are highly vascularized and grow rapidly. No encapsulation was noted [ Figure 4 ]. J Oral Maxillofac Pathol. Retrieved 29 June Surgical resection either open or increasingly endoscopic is the treatment of choice, usually performed with pre-operative embolisation to help with haemostasis.
He had no noteworthy family history or past medical history. Diagnostic and therapeutic management.